Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

09:10 EDT 18th October 2017 | BioPortfolio

Showing News Articles 1–25 of 430,000+

Wednesday 18th October 2017

Global Polyoxyethylene Sorbitan Monostearate Market Research Report Forecast 20172022 [Report Updated: 18092017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Polyoxyethylene Sorbitan Monostearate Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Polyoxyethylene Sorbitan Monostearate industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The re...

Global Lyophilized Powder Market Research Report Forecast 20172022 [Report Updated: 18092017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Lyophilized Powder Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Lyophilized Powder industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate...

Napo Pharmaceuticals Endorses Prevention Access Campaign’s U=U Consensus Statement for People Living With HIV/AIDS (PLWHA)

Napo Pharmaceuticals, Inc. (Napo), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), announced today that it has joined more than 400 organizations from 59 countries in supporting the ...

uniQure Presents New Preclinical Data on AMT-130 in Huntington's Disease at the ESGCT 25th Anniversary Congress in Berlin

One-time Administration of AMT-130 Demonstrates Survival Benefit and Functional Improvement of Huntington's Disease Symptoms in Preclinical Study IND-enabling Toxicology Study Initiated LEXINGTON, Mass. and AMSTERDAM, The Netherlands, Oct. 18, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe...

Prometric and Board of Pharmacy Specialities® Begin Partnership

Aligned to improve patient care and increase awareness of the need for BPS Board Certified Pharmacists Prometric, a trusted provider of market-leading test development and delivery solutions, was selected by the Board of Pharmacy Specialties® (BPS), to provide best-in-class test delivery services for its board certification examinations to more than 7...

Nicole Martin and Thomas Coffey Join Mercer’s Milwaukee Office as Relationship Managers

Mercer, a global consulting leader in advancing health, wealth and careers, and a wholly owned subsidiary of Marsh & McLennan Companies (NYSE: MMC), has appointment Nicole Martin and Thomas Coffey as Relationship Managers. Their responsibilities include creating long term solution strategies for mid-market growth sales in the Wisconsin area, specifical...

Altasciences Conducts Alcohol Drug-Drug Interaction Study for Amygdala Neurosciences Inc.

Vince & Associates Clinical Research, an Altasciences company, announced today that they are working with Amygdala Neurosciences Inc. to conduct a Phase 1b, proof-of-concept, dose-ranging study to evaluate the safety of the co-administration of ascending doses of ANS-6637 and ethanol in healthy male alcohol drinkers. The potential clinical indication for ...

Eccovia Solutions Announces Community Care Coordination Platform Now Hosted in Microsoft Azure Government

Eccovia Solutions announced today that they have strategically expanded their relationship with Microsoft by hosting their leading ClientTrack Platform on the Microsoft Azure Government cloud platform. All of Eccovia Solutions’ more than 1,300 clients are now hosted in this government-only instance of Azure, reaping the benefits of its comprehensive comp...

FluGen Awarded $14.4 million by the Department of Defense to Test Universal Flu Vaccine Against Mismatched Strains

FluGen Inc., announced today that it has been awarded a grant of $14.4 million through the DOD’s Congressionally Directed Medical Research Programs Peer Reviewed Medical Research Program’s (PRMRP) mechanism to conduct clinical challenge-studies against mismatched influenza strains with its lead universal flu vaccine, RedeeFlu™. Under the thr...

Quad Technologies Patents Novel T-Cell Activation Reagent for Car-T Cell Manufacturing

Quad Technologies, a leader in cell and gene therapy bioprocessing reagents, announced today the U.S. Patent and Trademark Office has awarded the company a new U.S. Patent, No. 9,790,467, titled “Methods and Compositions for activation or expansion of T lymphocytes”. According to Quad Technologies CEO Sean Kevlahan, the patent relates to a scala...

Nazneen Rahman: In tune with genetics

bmj;359/oct18_4/j4732/FAF1faDuncan SmithBiographyNazneen Rahman is professor of human genetics at the Institute of Cancer Research in London and head of the Cancer Genetics Unit at the Royal Marsden...

Global Dental Digital Xray Equipment Market Research Report Forecast 2017 to 2021 [Report Updated: 18092017] Prices from USD $2800

The Global Dental Digital Xray Equipment Market Research Report Forecast 20172021 is a valuable source of insightful data for business strategists. It provides the Dental Digital Xray Equipment industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate description of the value chain and its distr...

Global Automotive Airbag Fabric Market Research Report Forecast 2017 to 2022 [Report Updated: 09102017] Prices from USD $2800

Delivery of the Report will take 23 working days once order is placed.The Global Automotive Airbag Fabric Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Automotive Airbag Fabric industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provi...

Enyo Pharma SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11102017] Prices from USD $250

SummaryEnyo Pharma SA Enyo Pharma is a biopharmaceutical company that develops molecules modulating host functions for the treatment of acute and chronic viral infections. The company's technology develops tools combining biological experimentation and computational development to identify key cellular proteins controlling virus replication. Enyo Pharma has constructed a database made up of a libr...

Allergan's unusual deal with a Native American tribe could...

Allergan struck an unusual deal with the Saint Regis Mohawk Tribe to transfer patents of the eye drug Restasis, a move that gives the drug sovereign immunity from certain patent challenges. The loss in district court means that Allergan won't get much of the upside from the St. Regis deal, and analysts highlight the " Allergan , the drugmaker behind Botox, on Monday, had patents on one of its ...

Global Synthetic Surfactants Market Research Report Forecast 20172022 [Report Updated: 18092017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Synthetic Surfactants Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Synthetic Surfactants industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an ela...

Global Vascular Closure Devices VCDS Market Research Report Forecast 20172022 [Report Updated: 18092017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Vascular Closure Devices VCDS Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Vascular Closure Devices VCDS industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analy...

Priority Health Partners with Local Health Systems to Create Affordable Plan Options for Southeast Michigan Residents

Priority Health is committed to providing individual market consumers statewide options to help control their health care costs. As part of this commitment, Priority Health announces, today, its introduction of two new narrow networks in Southeast Michigan. St. John Providence and Saint Joseph Mercy Health System will serve as strategic partners in serving...

BRIEF—Priority review status for first PARP inhibitor application outside of ovarian cancer

The UK’s AstraZeneca and New Jersey-based Merck & Co have announced the US FDA will review an application…

Nation's Leading Fertility Therapy Company Appoints Life Sciences Veteran to Board of Directors

FDA Cleared Conception Kit® At-Home System By Conceivex Gives Couples New 'First Step' OptionFor Starting A Family Conceivex, maker of The Conception Kit® at-home system, today named veteran life sciences industry executive

PPD Hero Leads Team Supporting Multiple Sclerosis Research

Company’s Texas employees join Walk MS: Austin to spotlight life-changing clinical trials Pharmaceutical Product Development, LLC (PPD) is sponsoring

As patent due to expire, AHF calls on Gilead for 90% price cut on tenofovir-based drugs

Noting that with the patent ending and generics looming, USA-based global AIDS organization AIDS Healthcare…

Mirna Therapeutics Inc MIRN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17082017] Prices from USD $250

SummaryMirna Therapeutics Inc Mirna is a clinical stage biopharmaceutical company that develops and commercializes microRNA cancer therapeutics. The company through its microRNA replacement therapy technology develops products for cancer treatment. Its products MRX34, developed in such a way that it releases mimic of the naturally occurring microRNA tumor suppressor miR34 that is under expressed d...

BRIEF—Novartis publishes positive long-term data in rare blood disorder

Switzerland’s Novartis has published long-term study safety and efficacy data from the EXTEND study…

Pfizer set to review its consumer healthcare business

Pfizer has released a statement on its position concerning its consumer healthcare business, revealing that it will be considering a range of strategic alternatives as part of its efforts to best serve patients and maximise value for its shareholders


Quick Search
Advertisement
 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.